Marshall Wace’s Anbio Biotechnology NNNN Stock Holding History

Marshall Wace’s Portfolio NNNN Stock Details NNNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,443	Closed	-$389K	–	3619
2025 Q3	$389K	Buy	+10,443	New	+$469K	﹤0.01%	2326
2025 Q2	–	Sell	-43,629	Closed	-$325K	–	3303
2025 Q1	$325K	Buy	+43,629	New	+$298K	﹤0.01%	2239

Other funds holding NNNN

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's NNNN Position: Q4 2025 in Review

Marshall Wace sold out of Anbio Biotechnology (NNNN) in Q4 2025, closing a stake of 10,443 shares — an estimated $389K sold.

Marshall Wace first reported a position in NNNN in Q1 2025 and held it in 2 quarters. The position peaked at $389K in Q3 2025. 5 funds tracked by Wall St. Rank hold NNNN as of Q4 2025.

Marshall Wace reported no remaining Anbio Biotechnology position as of Q4 2025 after selling out during the quarter.
Marshall Wace sold 10,443 Anbio Biotechnology shares in Q4 2025, an estimated $389K.
Marshall Wace first reported a position in Anbio Biotechnology in Q1 2025 and held it in 2 quarters.
Marshall Wace's Anbio Biotechnology position peaked at $389K in Q3 2025.
5 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.